Myra Coppage

Summary

Affiliation: University of Rochester
Country: USA

Publications

  1. doi request reprint Leukemia specific loss of heterozygosity of MHC in a CLL patient: disease state impacts timing of confirmatory typing
    Myra Coppage
    Department of Pathology and Laboratory Medicine, University of Rochester Medical Center and the Wilmot Cancer Center, Rochester, NY, USA
    Hum Immunol 74:41-4. 2013
  2. pmc Lack of significant de novo HLA allosensitization in ventricular assist device recipients transfused with leukoreduced, ABO identical blood products
    Myra Coppage
    Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Strong Memorial Hospital, Rochester, NY, USA
    Hum Immunol 70:413-6. 2009

Collaborators

Detail Information

Publications2

  1. doi request reprint Leukemia specific loss of heterozygosity of MHC in a CLL patient: disease state impacts timing of confirmatory typing
    Myra Coppage
    Department of Pathology and Laboratory Medicine, University of Rochester Medical Center and the Wilmot Cancer Center, Rochester, NY, USA
    Hum Immunol 74:41-4. 2013
    ..Microarray based comparative genomic hybridization of tumor cells confirmed LOH at 6p...
  2. pmc Lack of significant de novo HLA allosensitization in ventricular assist device recipients transfused with leukoreduced, ABO identical blood products
    Myra Coppage
    Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Strong Memorial Hospital, Rochester, NY, USA
    Hum Immunol 70:413-6. 2009
    ..No patient developed broad sensitization (PRA>50%). In conclusion, The use of leukoreduced, irradiated, ABO identical blood products abrogates broad allosensitization in this highly transfused population...